Navigation Links
New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
Date:9/16/2013

e look forward to completing the acquisition in the coming months, which we believe will establish Mylan as a global injectables leader, with a significantly expanded and strengthened injectables portfolio, pipeline, platform and capabilities." The Company expects the transaction to close in Q4 2013, subject to remaining regulatory approvals and certain closing conditions. The Full Research Report on Mylan, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-11/MYL]

--

AstraZeneca PLC Research Report

On September 11, 2013, AstraZeneca PLC (AstraZeneca) announced that it has entered into a worldwide licensing agreement with Merck Co. Inc. (Merck) for the latter's oral small molecule inhibitor of WEE1 kinase (MK-1775). The Company informed that MK-1775 is undergoing evaluation in Phase IIa clinical studies in combination with standard of care therapies for the treatment of patients with certain types of ovarian cancer. Under the terms of agreement, AstraZeneca will pay $50 million upfront fee and will be responsible for all future clinical development, manufacturing and marketing, while Merck will be eligible to receive future payments tied to development and regulatory milestones plus sales-related payments and tiered royalties. "MK-1775 is a strong addition to AstraZeneca's growing oncology pipeline, which already includes a number of inhibitors of the DNA damage response," said Susan Galbraith, Head of AstraZeneca's Oncology Innovative Medicines Unit. "The compound has demonstrated encouraging clinical efficacy data and we intend to study it in a range of cancer types where there is a high unmet medical need." The Full Research Report on AstraZeneca PLC - including full detailed breakdown, analyst ratings and price targets - is avail
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
2. Research and Markets: Nanobiotechnology Applications, Markets and Companies - 2013 Report
3. Carbon Nanotubes (CNT) for Electronics & Electrics 2013-2023: Forecasts, Applications, Technologies
4. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
5. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
6. SpermCheck® Fertility, the Only FDA Approved At-Home Screening Test for Men to Determine Normal or Low Sperm Count, Now Available to Couples Planning or Struggling to Conceive
7. K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
8. K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
9. Pinnaclife Animal Health Features Seal N Heal Wound Shield in New Veterinary Dermatologist Tested and Approved Product Line!
10. Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
11. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... for Life Science organizations who need document translations. ... subject matter of their documents in advance with a ... help reduce time-to-delivery of translations, often a critical factor ... of error. , “All translations are inherently time-sensitive by ...
(Date:1/14/2014)... PA (PRWEB) January 14, 2014 Date: ... 11 p.m. , Location: Warrington Country Club, 1360 Almshouse ... B Foundation, the only national nonprofit organization solely dedicated ... the quality of life for those affected worldwide, will ... at Warrington Country Club in Warrington, Pa. , ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... to serve the wound care market. , Free ... 2012, Alliqua was restructured with a seasoned management ... strategy to become a leading provider of wound ...
(Date:1/14/2014)... WESTBOROUGH, Mass. , Jan. 14, 2014 ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that ... the United States Patent and Trademark Office ... for the treatment of fibrosis. The patent ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... nanotubes as the critical component of a robust terahertz ... and communication devices, sensors and non-invasive medical imaging systems ... systems. The polarizer developed by the Rice lab ... engineering and of physics and astronomy, is the most ...
... (OTCBB: SNGX) (Soligenix or the Company), a development stage ... Amendment to its Amended and Restated Certificate of Incorporation ... stock which will take effect tomorrow morning. ... an opportune time to effect a reverse stock split," ...
...  bioTheranostics, Inc., a bioMerieux company that develops innovative ... introduced a new product line of high medical ... called PRECIS Precision Medicine by bioTheranostics(SM). Precision medicine, ... diagnosis of primary tumor site and predictive biomarkers ...
Cached Biology Technology:Research at Rice University leads to nanotube-based device for communication, security, sensing 2Research at Rice University leads to nanotube-based device for communication, security, sensing 3Soligenix Announces 1 for 20 Reverse-Split of its Common Stock 2Soligenix Announces 1 for 20 Reverse-Split of its Common Stock 3Soligenix Announces 1 for 20 Reverse-Split of its Common Stock 4bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 2bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 3
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... in the Congo Basin to increase by 0.7 ... greenhouse gases by half, according to a study ... , Explosive population growth and inefficient agricultural practices ... Central Africa. A team of researchers from the ... affect longer-term temperatures in the region. Using a ...
(Date:4/15/2014)... systems soon could be powering the forklifts used in ... with faster refueling times than ever before, courtesy of ... Carriers (HHC). , The goal of the project is ... refuel at low pressure four to five times faster ... hydrogen a competitive advantage over batteries for a big ...
Breaking Biology News(10 mins):Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Study: Deforestation could intensify climate change in Congo Basin by half 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4
... may have more in common than previously thought. At ... Bejan and Penn State biologist James Marden. What they ... systems from animal locomotion to the formation of river ... Flows evolve to reduce friction or other forms of resistance, ...
... dismaying reports that a promising antitumor drug could, in theory, ... Japanese team of researchers that suggests a potentially better option. ... Journal of Experimental Medicine (online April 27). ... new blood vessels that feed growing tumors. Agents that block ...
... Each year, the Entomological Society of America (ESA) features ... are a lively question-and-answer, college bowl-style competition on ... an important and entertaining component of the ESA Annual ... five regional Branches will compete in the national competition ...
Cached Biology News:Unifying the animate and the inanimate designs of nature 2A longer lasting tumor blocker 2Entomological Society of America's Linnaean Games teams selected 2
... Fluoroskan Ascent FL ... fluorometric and luminometric measurement ... long list of advanced ... and Luminoskan Ascent. Fluoroskan ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... Roche Applied Science, which pioneered the blending ... High Fidelity and Expand Long Template PCR ... PCR System the first product of ... This new blend combines Taq DNA Polymerase ...
... 13 5'G AATTC3' 3'CTTAA G5' Inactivation Conditions: Heat ... precipitation. Storage Conditions: 10mM Tris-HCl (pH 7.5), 100mM ... 0.01% BSA, 50% glycerol. Shipping and Storage: Shipped ... One unit is defined as the amount of ...
Biology Products: